HM15912 Active clinical trials

Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects

This study looks at a new medicine, HM15912, for adults with Short Bowel Syndrome. We want to see if it's safe, how it works in the body, and if it could help. Participants will receive either the new medicine or a dummy medicine.